29 October 2018

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

29 October 2018 | n=23

  1. Levy ME, Greenberg AE, Magnus M, Younes N, et al.
    Immunosuppression and HIV Viremia Associated with More Atherogenic Lipid Profile in Older People with HIV.
    AIDS Res Hum Retroviruses 2018.

  2. Jean MJ, Fiches G, Hayashi T, Zhu J, et al.
    Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors.
    AIDS Res Hum Retroviruses 2018.

  3. Meiring S, Cohen C, de Gouveia L, du Plessis M, et al.
    Declining incidence of invasive meningococcal disease in South Africa: 2003-2016.
    Clin Infect Dis 2018.

  4. Riddler SA, Balkus JE, Parikh UM, Mellors JW, et al.
    Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the MTN-020/ASPIRE Phase III Trial of the Dapivirine Vaginal Ring.
    Clin Infect Dis 2018.

  5. .
    HIV-1 Proviral Sequence and Treatment Outcome of Virologically Suppressed Patients Switching to Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate: Erratum.
    J Acquir Immune Defic Syndr 2018;79:e111.

  6. Ammassari A, Stohr W, Antinori A, Molina JM, et al.
    Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.
    J Acquir Immune Defic Syndr 2018;79:481-490.

  7. Mustanski B, Morgan E, D'Aquila R, Birkett M, et al.
    Individual and Network Factors Associated with Racial Disparities in HIV Among Young Men who have sex with Men: Results from the Radar Cohort Study.
    J Acquir Immune Defic Syndr 2018.

  8. Montoya JL, Campbell LM, Paolillo EW, Ellis RJ, et al.
    Inflammation Relates to Poorer Complex Motor Performance among Adults Living with HIV on Suppressive Antiretroviral Therapy.
    J Acquir Immune Defic Syndr 2018.

  9. Mwinnyaa G, Gray RH, Grabowski MK, Ssekasanvu J, et al.
    Brief Report: Age-Disparate Relationships and HIV Prevalence Among Never Married Women in Rakai, Uganda.
    J Acquir Immune Defic Syndr 2018;79:430-434.

  10. Streed CG Jr, Goldstein Z, Poteat T, Mukherjee M, et al.
    Response to: Cardiovascular Risk Profile of Transgender Women with HIV.
    J Acquir Immune Defic Syndr 2018.

  11. Milam J, Jain S, Dube MP, Daar ES, et al.
    Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study among Individuals at Risk for HIV.
    J Acquir Immune Defic Syndr 2018.

  12. Moorhouse M, Maartens G, Francois Venter WD, Moosa MY, et al.
    Third-line antiretroviral therapy programme in the South African public sector: cohort description and virological outcomes.
    J Acquir Immune Defic Syndr 2018.

  13. Larouche A, Milton McSween KA, Calderon V, Fauteux-Daniel S, et al.
    Quasispecies Diversity Is a Major Risk Factor for Vertical Hepatitis C Virus Transmission.
    J Infect Dis 2018.

  14. Appourchaux R, Delpeuch M, Zhong L, Burlaud-Gaillard J, et al.
    Functional mapping of regions involved in the negative imprinting of virion particles infectivity and in target cell protection by the Interferon-Induced Transmembrane Protein 3 (IFITM3) against HIV-1.
    J Virol 2018.

  15. Li S, Ahmad I, Shi J, Wang B, et al.
    Murine leukemia virus glycosylated Gag reduces murine SERINC5 protein expression at steady-state levels via endosome/lysosome pathway to counteract the SERINC5 antiretroviral activity.
    J Virol 2018.

  16. Cai Y, Abdel-Mohsen M, Tomescu C, Xue F, et al.
    BCL6 Inhibitor-mediated Downregulation of pSAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation.
    J Virol 2018.

  17. Lo M, Zhu J, Hansen SG, Carroll T, et al.
    Acute infection and subsequent subclinical reactivation of herpes simplex virus-2 after vaginal inoculation of rhesus macaques.
    J Virol 2018.

  18. Murakoshi H, Kuse N, Akahoshi T, Yu Z, et al.
    Broad recognition of circulating HIV-1 by HIV-1-specific CTLs with strong ability to suppress HIV-1 replication.
    J Virol 2018.

  19. Yi DR, An N, Liu ZL, Xu FW, et al.
    Human MxB inhibits the replication of HCV.
    J Virol 2018.

  20. James KL, de Silva T, Brown K, Whittle H, et al.
    LOW-BIAS RNA SEQUENCING OF THE HIV-2 GENOME FROM BLOOD PLASMA.
    J Virol 2018.

  21. Foreman KJ, Marquez N, Dolgert A, Fukutaki K, et al.
    Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.
    Lancet 2018.

  22. Palma P, Cotugno N, Rossi P, Giaquinto C, et al.
    The Mission is Remission: Hope for Controlling HIV Virus Replication Without ART in Early Treated Perinatally HIV Infected Children.
    Pediatr Infect Dis J 2018.

  23. Torjesen I.
    HIV diagnoses fall by a quarter after PrEP roll-out in Australia.
    BMJ 2018;363:k4382.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

19 November 2018

12 November 2018

05 November 2018

29 October 2018

22 October 2018


29 October 2018

Multidisciplinary Journal Club

  1. Anand SS, Bosch J, Eikelboom JW, Connolly SJ, et al.
    Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Lancet. 2018;391:219-229.

  2. Banales JM, Inarrairaegui M, Arbelaiz A, Milkiewicz P, et al.
    Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis.
    Hepatology. 2018 Oct 16. doi: 10.1002/hep.30319.

  3. Ossenkoppele R, Rabinovici GD, Smith R, Cho H, et al.
    Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
    JAMA. 2018;320:1151-1162.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016